www.reviewofoptometry.com
Open in
urlscan Pro
188.114.97.3
Public Scan
URL:
https://www.reviewofoptometry.com/
Submission: On October 16 via api from CA — Scanned from NL
Submission: On October 16 via api from CA — Scanned from NL
Form analysis 1 forms found in the DOM
<form class="gsc-search-box gsc-search-box-tools" accept-charset="utf-8">
<table cellspacing="0" cellpadding="0" role="presentation" class="gsc-search-box">
<tbody>
<tr>
<td class="gsc-input">
<div class="gsc-input-box" id="gsc-iw-id1">
<table cellspacing="0" cellpadding="0" role="presentation" id="gs_id50" class="gstl_50 gsc-input" style="width: 100%; padding: 0px;">
<tbody>
<tr>
<td id="gs_tti50" class="gsib_a"><input autocomplete="off" type="text" size="10" class="gsc-input" name="search" title="search" aria-label="search" id="gsc-i-id1" dir="ltr" spellcheck="false"
style="width: 100%; padding: 0px; border: none; margin: 0px; height: auto; outline: none;"></td>
<td class="gsib_b">
<div class="gsst_b" id="gs_st50" dir="ltr"><a class="gsst_a" href="javascript:void(0)" title="Clear search box" role="button" style="display: none;"><span class="gscb_a" id="gs_cb50" aria-hidden="true">×</span></a></div>
</td>
</tr>
</tbody>
</table>
</div>
</td>
<td class="gsc-search-button"><button class="gsc-search-button gsc-search-button-v2"><svg width="13" height="13" viewBox="0 0 13 13">
<title>search</title>
<path
d="m4.8495 7.8226c0.82666 0 1.5262-0.29146 2.0985-0.87438 0.57232-0.58292 0.86378-1.2877 0.87438-2.1144 0.010599-0.82666-0.28086-1.5262-0.87438-2.0985-0.59352-0.57232-1.293-0.86378-2.0985-0.87438-0.8055-0.010599-1.5103 0.28086-2.1144 0.87438-0.60414 0.59352-0.8956 1.293-0.87438 2.0985 0.021197 0.8055 0.31266 1.5103 0.87438 2.1144 0.56172 0.60414 1.2665 0.8956 2.1144 0.87438zm4.4695 0.2115 3.681 3.6819-1.259 1.284-3.6817-3.7 0.0019784-0.69479-0.090043-0.098846c-0.87973 0.76087-1.92 1.1413-3.1207 1.1413-1.3553 0-2.5025-0.46363-3.4417-1.3909s-1.4088-2.0686-1.4088-3.4239c0-1.3553 0.4696-2.4966 1.4088-3.4239 0.9392-0.92727 2.0864-1.3969 3.4417-1.4088 1.3553-0.011889 2.4906 0.45771 3.406 1.4088 0.9154 0.95107 1.379 2.0924 1.3909 3.4239 0 1.2126-0.38043 2.2588-1.1413 3.1385l0.098834 0.090049z">
</path>
</svg></button></td>
<td class="gsc-clear-button">
<div class="gsc-clear-button" title="clear results"> </div>
</td>
</tr>
</tbody>
</table>
</form>Text Content
Toggle navigation
Leadership in clinical care
×
search
* HOME
* CE
* TOPICS
* * Case Reports
* Coding
* Contact Lenses & Solutions
* Cornea
* Diagnostics
* Dry Eye
* Eyelids
* Glaucoma
* Low Vision
* Neuro-ophthalmic Disorders
* News
* Ophthalmic Lenses & Dispensary
* Optometric Study Center
* Pharmaceuticals
* Practice Management
* Products
* Retina
* Surgery
* Systemic Disease
* Technology
* Multimedia
* Web Exclusives
* EVENTS
* * CE Programs
* Educational Programs (Non-CE)
* JOBS
Today's Spotlight
REACH NEW HEIGHTS
Advance your practice with these fast-growing services.
Read More
Today's Spotlight
A HOLE IN THE IRIS
The Academy of Ophthalmology’s registry generates valuable insights— but
excludes optometry practices, to its detriment.
Read More
Today's Spotlight
THE REVIEW OF OPTOMETRY PHOTO ATLAS OF OCULAR DISEASE
This new visual guide documents over 200 presentations encountered in clinical
practice.
Read More
Today's Spotlight
BE AWARE OF WAXING AND WANING SYMPTOMS
Recurrence of complaints in the absence of significant signs can be a red flag.
Read More
Today's Spotlight
DOXY: WORTH ITS MOXIE
When considering the role of oral antibiotics, there are many situations in
which an ocular condition would necessitate prescriptive use.
Read More
Oct 16
Oct 15
Oct 14
Oct 13
Oct 12
THE NEWS FEED
NEW EVIDENCE STRENGTHENS THE LINK BETWEEN AIR POLLUTION AND KERATOCONUS
October 16, 2024
DEEPER MACULAR STAPHYLOMA INCREASES RETINOSCHISIS RISK
October 16, 2024
NEW STUDY HIGHLIGHTS IMPORTANCE OF ACCURATE MAGNIFICATION CORRECTION IN RETINAL
IMAGING
October 16, 2024
BLACK GLAUCOMA PATIENTS LESS LIKELY TO UNDERGO MIGS PROCEDURE
October 15, 2024
OPTOMETRIC PRACTICE DATA SHOWN TO IMPROVE OCT REFERENCE DATABASE ACCURACY
October 15, 2024
POST-OP ENDOPHTHALMITIS RATES LOWER IN CASES OF IOL EXCHANGE
October 15, 2024
REBOUND TONOMETRY PROVIDED FOR THE SEATED SLIT LAMP PATIENT
October 11, 2024
EN FACE OCT BETTER THAN B-SCAN IN DIAGNOSIS OF EARLY MACULAR ATROPHY IN AMD
October 11, 2024
OLDER AGE, MODERATE VISUAL IMPAIRMENT LINKED TO WORSE GA OUTCOMES
October 11, 2024
RESEARCHERS EXPLORE POSSIBLE BLOOD TEST FOR AMD
October 11, 2024
NEW STUDY HIGHLIGHTS LIKELIHOOD OF MACULAR RETINOSCHISIS IN ELDERLY HIGH MYOPES
October 10, 2024
IN UK, SLTS BY OPTOMETRY AS SAFE AND EFFECTIVE AS THOSE DONE BY OPHTHALMOLOGY
October 10, 2024
TWO FUNDUS CAMERA CANDIDATES FOR DR SCREENING SHOW PROMISE
October 10, 2024
IN EARLY, MODERATE POAG, STRAIN ON LAMINA CRIBROSA AFFECTS RNFL THICKNESS
DECREASE
October 09, 2024
FRAGMENTED CIRCADIAN RHYTHM MAY INCREASE DR RISK
October 09, 2024
AXIAL ELONGATION, MYOPIA PROGRESSION VARY BY REGION, ETHNICITY AND AGE
October 09, 2024
OUTER RETINAL THINNING MAY SIGNAL COGNITIVE DECLINE IN THOSE WITH EARLY AMD
October 08, 2024
VESSEL DENSITY ON OCT-A MAY DIFFERENTIATE TRUE FROM PSEUDO OPTIC DISC SWELLING
October 08, 2024
STUDY HIGHLIGHTS UNIQUE OCULAR CHARACTERISTICS OF CHILDREN WITH HISTORY OF ROP
October 08, 2024
CALIFORNIA NOTES IMPROVEMENT IN ROP CARE, REDUCING INCIDENCE AND RACIAL
DISPARITIES
October 07, 2024
INTRARETINAL HYPERREFLECTIVE BODIES IN INTERMEDIATE, LATE AMD RELATE TO
MIGRATING RPE CELLS
October 07, 2024
SUCCESS OF TRABECULECTOMY LOW IN GLAUCOMA PATIENTS OF AFRICAN ANCESTRY
October 07, 2024
STUDY DESCRIBES RISK FACTORS FOR OCULAR COMPLICATIONS IN HZO
October 04, 2024
STUDY IDENTIFIES OCT-A PARAMETERS TO PREDICT DME TREATMENT RESPONSE
October 04, 2024
RESEARCHERS IDENTIFY RISK FACTORS FOR NEOVASCULAR GLAUCOMA AFTER VEIN OCCLUSION
October 04, 2024
GLAUCOMA PATIENTS USING ALPHA AGONISTS MAY HAVE HIGHER ALZHEIMER’S RISK
October 03, 2024
RESEARCH UNCOVERS DIFFERENCES IN MNV RESPONSE TO ANTI-VEGF THERAPY
October 03, 2024
BE ON GUARD FOR FELLOW-EYE DISEASE IN PXS
October 03, 2024
HYDROXYCHLOROQUINE INTAKE IMPACTS ONL THINNING
October 02, 2024
INVERTED ILM FLAP BEST TECHNIQUE FOR MACULAR ATROPHY IN MYOPIC TRACTION
MACULOPATHY
October 02, 2024
OSSN RISK FACTORS FOR DEVELOPMENT OF LIMBAL STEM CELL DEFICIENCY IDENTIFIED
October 02, 2024
PUPILS CONSTRICT AT HIGH ALTITUDES, STUDY FINDS
October 01, 2024
ADJUVANT CHEMO AFTER ENUCLEATION REDUCES RECURRENCE, IMPROVES SURVIVAL IN
RETINOBLASTOMA
October 01, 2024
MYOPIA EPIDEMIC PROJECTED TO AFFECT NEARLY 740 MILLION CHILDREN WORLDWIDE BY
2050
October 01, 2024
MYOPIC KIDS MORE LIKELY TO EXPERIENCE DRY EYE THAN NON-MYOPES
September 30, 2024
AGE AT DIAGNOSIS PRIME FACTOR IN AMBLYOPIA TREATMENT DISPARITIES; SOCIOECONOMIC
STATUS ALSO SIGNIFICANT
September 30, 2024
ATRIAL FIBRILLATION ACCELERATES VF LOSS IN GLAUCOMA PATIENTS
September 30, 2024
WIDEFIELD OCT-A REVEALS EFFECTS OF HIGH MYOPIA ON RETINAL VASCULAR STRUCTURES
September 27, 2024
PRIMARY SYSTEMIC VASCULITIS-ASSOCIATED OPTIC NEURITIS YIELDS POOR PROGNOSIS
September 27, 2024
CHOROIDAL DRAINAGE SYSTEM POTENTIAL IMAGING BIOMARKER FOR OCULAR DISEASES
September 27, 2024
RESEARCHERS UNCOVER KEY RISK FACTORS FOR CENTRAL SEROUS CHORIORETINOPATHY
September 26, 2024
RETINA HELPS REVEAL NEW DEMENTIA RISK FACTOR
September 26, 2024
OCT SHOW PROMISE AS TOOL TO PREDICT AL
September 26, 2024
FIRST VIDEO MAGNIFIER FOR VISUALLY IMPAIRED IPHONE USERS
September 25, 2024
EYE DOCTORS WHO WEAR GLASSES PERCEIVED AS SMART, BUT MORE ALOOF
September 25, 2024
NEW OCT METHOD COULD AID TILTED DISC ASSESSMENT IN MYOPIC GLAUCOMA
September 25, 2024
INDICATIONS, PROCEDURES FOR KERATOPLASTY SHIFTED OVER TWO DECADES
September 25, 2024
NEW OSD IMAGING SYSTEM INTEGRATES AI
September 24, 2024
ANALYSIS IDENTIFIES NEW RISK FACTORS FOR POSTERIOR CAPSULAR RUPTURE
September 24, 2024
UVEITIS COMMON IN HERPES ZOSTER OPHTHALMICUS, LINKED TO VISION COMPLICATIONS
September 24, 2024
Previous Load Next Five Next
LOOK INSIDE THE CURRENT ISSUE
OCTOBER 15, 2024
TABLE OF CONTENTS
READ PDF EDITION
ARCHIVE
SUBSCRIPTIONS
FEATURES
Clinical Research
THE SKEPTICAL EYE: WHY AND HOW TO INTERPRET MEDICAL RESEARCH CRITICALLY
Whether by mistake or malice, the numbers cited in studies may be less reliable
than we think.
Neuro
GUIDELINES FOR IIH MANAGEMENT IN OPTOMETRIC PRACTICE
Explore the causes and symptoms of this condition as well as effective
management strategies.
Neuro
NEURODEGENERATIVE DISEASE: UNCOVERING THE OCULAR CONNECTION
The eye has recently been catapulted forward as a window inside the brain’s
function, due to derivation from the same embryonic cells. We can use certain
biomarkers to diagnose better or prevent these debilitating conditions.
Neuro
PRACTICAL NEURO-OPHTHALMIC DISEASE MANAGEMENT
With knowledge and experience, many patients with these disorders can be managed
in an optometric practice.
Neuro
THE CRANIAL NEUROPATHIES: OCULOMOTOR, TROCHLEAR AND ABDUCENS
A guide to the clinical indications, causes and management strategies for the
three nerve palsies affecting eye movement.
Neuro
WHEN OPHTHALMICS AND NEURO COLLIDE
Many ocular conditions can overlap or masquerade as suspected central nervous
system tumors. Here are some cases to consider for distinguishing one from
another.
DEPARTMENTS
Outlook
A HOLE IN THE IRIS
The Academy of Ophthalmology’s registry generates valuable insights— but
excludes optometry practices, to its detriment.
You Be the Judge
DISASTER WAITING TO HAPPEN
Mentally and physically challenged patients present unique difficulties to the
ophthalmic clinician.
Retina Quiz
EYE SPOT TROUBLE
Can you identify this patient’s risk factors?
Glaucoma Grand Rounds
HOW TO LOSE A PATIENT
Someone's experience of feeling they aren't being listened to can cost you their
care.
Diagnostic Quiz
MAKING CONTACT
What might cause a patient to have “crusty eyes” and ocular surface irritation?
Ocular Surface Review
NUTRITION’S SECOND ACT IN DRY EYE DISEASE
The impact of diet and supplements on ocular surface health has recently drawn
renewed attention and even a bit of scrutiny.
Clinical Quandaries
OZEMPIC ON THE LOOSE
This popular medication for diabetes management can lead to ocular
complications.
Through My Eyes
REACH NEW HEIGHTS
Advance your practice with these fast-growing services.
Chairside
SICK OF IT
Taking care of ill patients can be challenging.
Therapeutic Review
SUPPORTING CORNEAL REPAIR
Available adjuncts to standard therapy can enhance treatment in cases of erosion
or dystrophy.
Surgical Minute
UPDATE ON ENDO
A rundown of recent and investigative breakthroughs in targeted corneal
surgeries and therapies.
Focus on Refraction
VEP TO THE RESCUE
Using this can aid in the diagnostic and therapeutic processes.
UPCOMING EVENTS
NOVEMBER 15-17, 2024
DECEMBER 6-7, 2024
DECEMBER 7-8, 2024
E-NEWSLETTERS
PRACTICE PEARLS
Expert clinician Paul Karpecki, OD, provides practical insights and management
strategies for a wide array of ocular conditions.
OCCRS E-NEWSLETTER
A quarterly e-newsletter by Optometric Cornea, Cataract and Refractive Society
(OCCRS) covering the latest information on cornea, cataract and refractive
surgery, comanagement and leading technologies.
OPTOMETRIC RETINA SOCIETY E-NEWSLETTER
Keep up to date on the latest research and clinical findings in retinal disease
care with this quarterly publication from the ORS.
OPTOMETRIC PHYSICIAN E-JOURNAL
A weekly e-journal edited by Art Epstein, OD, featuring incisive commentary,
timely research summaries and late-breaking news.
TO SUBSCRIBE TO THESE AND OTHERS, CLICK HERE
CONTINUING EDUCATION
October 2024 • 2.00 Credits
GUIDELINES FOR IIH MANAGEMENT IN OPTOMETRIC PRACTICE
September 2024 • 2.00 Credits
CAN YOU SPOT THESE DRUG-INDUCED OCULAR SIDE EFFECTS?
August 2024 • 2.00 Credits
A STEPWISE APPROACH TO DIAGNOSING DRY EYE DISEASE
July 2024 • 2.00 Credits
WHEN ITS NOT AMBLYOPIA: THE DIFFERENTIAL OF FUNCTIONAL VS. PATHOLOGICAL VISION
LOSS
View More CE
ADDITIONAL PUBLICATIONS
* WELLNESS ESSENTIALS FOR CLINICAL PRACTICE - 4TH EDITION
In this special annual supplement, members of the Ocular Wellness & Nutrition
Society (OWNS) contribute 10 articles on the intersection of physical
wellness and eye health.
Supported by Bausch + Lomb
* TWO TORICS, ONE UNMATCHED DESIGN
* A BREAKTHROUGH IN NUTRITIONAL SUPPLEMENTATION FOR DRY EYES
* ANNUAL CONTACT LENSES AND LENS CARE GUIDE - 2024
* PRACTICAL MATTERS IN MYOPIA MANAGEMENT - 2024
* JULY OPHTHALMIC PRODUCT GUIDE
View More Publications
REVIEW OF CORNEA & CONTACT LENSES
SEPTEMBER/OCTOBER 2024
TABLE OF CONTENTS
READ DIGITAL EDITION
READ PDF EDITION
* AVOID THESE COMMON SCLERAL LENS MISTAKES
Novices may be unaware of certain intricacies these lenses possess, which can
make a big difference in outcomes.
* CLINICAL APPLICATIONS OF TODAY’S SCLERAL LENS RESEARCH
Catch up on the latest findings and how they can apply to clinical practice.
* SCLERAL LENS DESIGN: BEYOND THE VAULT
Creating proper secondary and peripheral curves helps prevent issues of
comfort and vision quality.
* OVERCOMING OBSTACLES WITH SCLERAL LENS FITTING
Follow along with these two tough cases to sharpen your techniques and help
set expectations for patients with severe corneal compromise.
* MASTER ELEVATION-DRIVEN CONTACT LENS FITTING
See how prioritizing sagittal metrics is changing the approach to design
across modalities.
* LESSONS LEARNED AT ARVO 2024
An abstract review of the latest, intriguing and clinically practical cornea
and contact lens research papers presented at this year’s meeting.
View More
Women In Optometry continues to be published online, with regular updates on
practice design, practice success, news, trends and perspectives. Visit
womeninoptometry.com.
JOB OF THE WEEK
Home Current Issue Subscribe e-Newsletters Continuing Education Meetings
Archives
Patient Handouts Optometric Study Center Editorial Staff Business Staff Media
Kit Multimedia Web Exclusives
Contact Us Privacy Policy Do Not Sell My Personal Information Manage Preferences
Classifieds
Copyright © 2024 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is
prohibited.
×
FULL IMAGE
WE CARE ABOUT YOUR PRIVACY
We and our 57 partners store and/or access information on a device, such as
unique IDs in cookies to process personal data. You may accept or manage your
choices by clicking below, including your right to object where legitimate
interest is used, or at any time in the privacy policy page. These choices will
be signaled to our partners and will not affect browsing data.
WE AND OUR PARTNERS PROCESS DATA TO PROVIDE:
Use precise geolocation data. Actively scan device characteristics for
identification. Store and/or access information on a device. Personalised
advertising and content, advertising and content measurement, audience research
and services development. List of Partners (vendors)
I Accept Show Purposes
ABOUT YOUR PRIVACY
We process your data to deliver content or advertisements and measure the
delivery of such content or advertisements to extract insights about our
website. We share this information with our partners on the basis of consent and
legitimate interest. You may exercise your right to consent or object to a
legitimate interest, based on a specific purpose below or at a partner level in
the link under each purpose. These choices will be signaled to our vendors
participating in the Transparency and Consent Framework.
More information
Allow All
MANAGE CONSENT PREFERENCES
STRICTLY NECESSARY COOKIES
Always Active
These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to block
or alert you about these cookies, but some parts of the site will not then work.
These cookies do not store any personally identifiable information.
TARGETING COOKIES
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.
PERFORMANCE COOKIES
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.
FUNCTIONAL COOKIES
Functional Cookies
These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then some
or all of these services may not function properly.
STORE AND/OR ACCESS INFORMATION ON A DEVICE 51 PARTNERS CAN USE THIS PURPOSE
Store and/or access information on a device
Cookies, device or similar online identifiers (e.g. login-based identifiers,
randomly assigned identifiers, network based identifiers) together with other
information (e.g. browser type and information, language, screen size, supported
technologies etc.) can be stored or read on your device to recognise it each
time it connects to an app or to a website, for one or several of the purposes
presented here.
List of IAB Vendors | View Illustrations
PERSONALISED ADVERTISING AND CONTENT, ADVERTISING AND CONTENT MEASUREMENT,
AUDIENCE RESEARCH AND SERVICES DEVELOPMENT 57 PARTNERS CAN USE THIS PURPOSE
Personalised advertising and content, advertising and content measurement,
audience research and services development
* USE LIMITED DATA TO SELECT ADVERTISING 46 PARTNERS CAN USE THIS PURPOSE
Switch Label
Advertising presented to you on this service can be based on limited data,
such as the website or app you are using, your non-precise location, your
device type or which content you are (or have been) interacting with (for
example, to limit the number of times an ad is presented to you).
View Illustrations
Object to Legitimate Interests Remove Objection
* CREATE PROFILES FOR PERSONALISED ADVERTISING 39 PARTNERS CAN USE THIS PURPOSE
Switch Label
Information about your activity on this service (such as forms you submit,
content you look at) can be stored and combined with other information about
you (for example, information from your previous activity on this service and
other websites or apps) or similar users. This is then used to build or
improve a profile about you (that might include possible interests and
personal aspects). Your profile can be used (also later) to present
advertising that appears more relevant based on your possible interests by
this and other entities.
View Illustrations
* USE PROFILES TO SELECT PERSONALISED ADVERTISING 39 PARTNERS CAN USE THIS
PURPOSE
Switch Label
Advertising presented to you on this service can be based on your advertising
profiles, which can reflect your activity on this service or other websites
or apps (like the forms you submit, content you look at), possible interests
and personal aspects.
View Illustrations
* CREATE PROFILES TO PERSONALISE CONTENT 13 PARTNERS CAN USE THIS PURPOSE
Switch Label
Information about your activity on this service (for instance, forms you
submit, non-advertising content you look at) can be stored and combined with
other information about you (such as your previous activity on this service
or other websites or apps) or similar users. This is then used to build or
improve a profile about you (which might for example include possible
interests and personal aspects). Your profile can be used (also later) to
present content that appears more relevant based on your possible interests,
such as by adapting the order in which content is shown to you, so that it is
even easier for you to find content that matches your interests.
View Illustrations
* USE PROFILES TO SELECT PERSONALISED CONTENT 11 PARTNERS CAN USE THIS PURPOSE
Switch Label
Content presented to you on this service can be based on your content
personalisation profiles, which can reflect your activity on this or other
services (for instance, the forms you submit, content you look at), possible
interests and personal aspects. This can for example be used to adapt the
order in which content is shown to you, so that it is even easier for you to
find (non-advertising) content that matches your interests.
View Illustrations
* MEASURE ADVERTISING PERFORMANCE 52 PARTNERS CAN USE THIS PURPOSE
Switch Label
Information regarding which advertising is presented to you and how you
interact with it can be used to determine how well an advert has worked for
you or other users and whether the goals of the advertising were reached. For
instance, whether you saw an ad, whether you clicked on it, whether it led
you to buy a product or visit a website, etc. This is very helpful to
understand the relevance of advertising campaigns.
View Illustrations
Object to Legitimate Interests Remove Objection
* MEASURE CONTENT PERFORMANCE 16 PARTNERS CAN USE THIS PURPOSE
Switch Label
Information regarding which content is presented to you and how you interact
with it can be used to determine whether the (non-advertising) content e.g.
reached its intended audience and matched your interests. For instance,
whether you read an article, watch a video, listen to a podcast or look at a
product description, how long you spent on this service and the web pages you
visit etc. This is very helpful to understand the relevance of
(non-advertising) content that is shown to you.
View Illustrations
Object to Legitimate Interests Remove Objection
* UNDERSTAND AUDIENCES THROUGH STATISTICS OR COMBINATIONS OF DATA FROM
DIFFERENT SOURCES 33 PARTNERS CAN USE THIS PURPOSE
Switch Label
Reports can be generated based on the combination of data sets (like user
profiles, statistics, market research, analytics data) regarding your
interactions and those of other users with advertising or (non-advertising)
content to identify common characteristics (for instance, to determine which
target audiences are more receptive to an ad campaign or to certain
contents).
View Illustrations
Object to Legitimate Interests Remove Objection
* DEVELOP AND IMPROVE SERVICES 49 PARTNERS CAN USE THIS PURPOSE
Switch Label
Information about your activity on this service, such as your interaction
with ads or content, can be very helpful to improve products and services and
to build new products and services based on user interactions, the type of
audience, etc. This specific purpose does not include the development or
improvement of user profiles and identifiers.
View Illustrations
Object to Legitimate Interests Remove Objection
* USE LIMITED DATA TO SELECT CONTENT 6 PARTNERS CAN USE THIS PURPOSE
Switch Label
Content presented to you on this service can be based on limited data, such
as the website or app you are using, your non-precise location, your device
type, or which content you are (or have been) interacting with (for example,
to limit the number of times a video or an article is presented to you).
View Illustrations
Object to Legitimate Interests Remove Objection
List of IAB Vendors
USE PRECISE GEOLOCATION DATA 14 PARTNERS CAN USE THIS PURPOSE
Use precise geolocation data
With your acceptance, your precise location (within a radius of less than 500
metres) may be used in support of the purposes explained in this notice.
List of IAB Vendors
ACTIVELY SCAN DEVICE CHARACTERISTICS FOR IDENTIFICATION 3 PARTNERS CAN USE THIS
PURPOSE
Actively scan device characteristics for identification
With your acceptance, certain characteristics specific to your device might be
requested and used to distinguish it from other devices (such as the installed
fonts or plugins, the resolution of your screen) in support of the purposes
explained in this notice.
List of IAB Vendors
ENSURE SECURITY, PREVENT AND DETECT FRAUD, AND FIX ERRORS 49 PARTNERS CAN USE
THIS PURPOSE
Always Active
Your data can be used to monitor for and prevent unusual and possibly fraudulent
activity (for example, regarding advertising, ad clicks by bots), and ensure
systems and processes work properly and securely. It can also be used to correct
any problems you, the publisher or the advertiser may encounter in the delivery
of content and ads and in your interaction with them.
List of IAB Vendors | View Illustrations
DELIVER AND PRESENT ADVERTISING AND CONTENT 42 PARTNERS CAN USE THIS PURPOSE
Always Active
Certain information (like an IP address or device capabilities) is used to
ensure the technical compatibility of the content or advertising, and to
facilitate the transmission of the content or ad to your device.
List of IAB Vendors | View Illustrations
MATCH AND COMBINE DATA FROM OTHER DATA SOURCES 40 PARTNERS CAN USE THIS PURPOSE
Always Active
Information about your activity on this service may be matched and combined with
other information relating to you and originating from various sources (for
instance your activity on a separate online service, your use of a loyalty card
in-store, or your answers to a survey), in support of the purposes explained in
this notice.
List of IAB Vendors
LINK DIFFERENT DEVICES 35 PARTNERS CAN USE THIS PURPOSE
Always Active
In support of the purposes explained in this notice, your device might be
considered as likely linked to other devices that belong to you or your
household (for instance because you are logged in to the same service on both
your phone and your computer, or because you may use the same Internet
connection on both devices).
List of IAB Vendors
IDENTIFY DEVICES BASED ON INFORMATION TRANSMITTED AUTOMATICALLY 36 PARTNERS CAN
USE THIS PURPOSE
Always Active
Your device might be distinguished from other devices based on information it
automatically sends when accessing the Internet (for instance, the IP address of
your Internet connection or the type of browser you are using) in support of the
purposes exposed in this notice.
List of IAB Vendors
Back Button
COOKIE LIST
Search Icon
Filter Icon
Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label
Confirm My Choices